Skip to main content

Articles

Onivyde (Irinotecan Liposome Injection) a New Treatment Option for Patients with Metastatic Pancreatic Cancer

Keytruda (Pembrolizumab) First PD-1 Inhibitor Approved for the Treatment of Patients with Metastatic Non–Small-Cell Lung Cancer Expressing PD-L1

Imlygic (Talimogene Laherparepvec): First Oncolytic Viral Therapy for the Treatment of Patients with Recurrent Melanoma

Finacia Foam (Azelaic Acid) the Newest Topical Treatment FDA Approved for the Treatment of Inflammatory Lesions of Rosacea

Ibrance (Palbociclib): First CDK4 and CDK6 Inhibitor Approved for Postmenopausal Women with Metastatic Breast Cancer

Convergence in Healthcare: Providers, Employers, and Health Plans

Original Research

Patient Characteristics and Prescribing Patterns Associated with Sofosbuvir Treatment for Chronic HCV Infection in a Commercially Insured Population

Stakeholder Perspective

Taking Steps to Cure Chronic Hepatitis C Virus Infection

Original Research

Patient Preferences Regarding Rheumatoid Arthritis Therapies: A Conjoint Analysis

Stakeholder Perspective

Challenges in the Assessment of Patient Preferences among RA Therapies

Practice Management

Inpatient Utilization and Costs for Medicare Fee-for-Service Beneficiaries with Heart Failure

Stakeholder Perspective

Validating the Impact of Heart Failure Through the Law of Large Numbers

FDA Approvals, In the News

Venclexta FDA Approved for Patients with CLL

Page 113 of 244
Results 1121 - 1130 of 2436